401k Plan data: AMBIOPHARM, INC PROFIT SHARING PLAN plan

AMBIOPHARM, INC PROFIT SHARING PLAN 401k Plan overview

Plan Name	AMBIOPHARM, INC PROFIT SHARING PLAN
Plan identification number	001

AMBIOPHARM, INC PROFIT SHARING PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

AMBIOPHARM, INC. has sponsored the creation of one or more 401k plans.

Company Name: AMBIOPHARM, INC.

Employer identification number (EIN): 223940281

NAIC Classification: 541700

Additional information about AMBIOPHARM, INC.

Jurisdiction of Incorporation: Nevada Department of State

Incorporation Date: 2007-05-07

Company Identification Number: 20071702782

Legal Registered Office Address: 3520 WYNN RD
SUITE 1
LAS VEGAS
United States of America (USA)
89103

More information about AMBIOPHARM, INC.

Form 5500 Filing Information

Submission information for form 5500 for 401k plan AMBIOPHARM, INC PROFIT SHARING PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2022-01-01 TERESA CHEEK 2023-10-15 TERESA CHEEK 2023-10-15
001 2021-01-01
001 2020-01-01
001 2020-01-01
001 2019-01-01
001 2018-01-01 SNOW WANG 2019-10-13 JUNCAI BAI 2019-10-13
001 2017-01-01
001 2016-01-01
001 2015-01-01
001 2014-01-01 SNOW WANG 2015-06-18 JUNCAI BAI 2015-06-18
001 2013-01-01 SNOW WANG 2014-07-10 JUNCAI BAI 2014-07-10
001 2012-01-01 SNOW WANG 2013-05-23 JUNCAI BAI 2013-05-28
001 2011-01-01 SNOW WANG 2012-06-11 JUNCAI BAI 2012-06-11
001 2010-01-01 SNOW WANG 2011-07-01 JUNCAI BAI 2011-07-01

Plan id#	Filing Submission Date	Name of Administrator	Date Administrator Signed	Name of Company Sponsor	Date Sponsor Signed
001	2022-01-01	TERESA CHEEK	2023-10-15	TERESA CHEEK	2023-10-15
001	2021-01-01
001	2020-01-01
001	2020-01-01
001	2019-01-01
001	2018-01-01	SNOW WANG	2019-10-13	JUNCAI BAI	2019-10-13
001	2017-01-01
001	2016-01-01
001	2015-01-01
001	2014-01-01	SNOW WANG	2015-06-18	JUNCAI BAI	2015-06-18
001	2013-01-01	SNOW WANG	2014-07-10	JUNCAI BAI	2014-07-10
001	2012-01-01	SNOW WANG	2013-05-23	JUNCAI BAI	2013-05-28
001	2011-01-01	SNOW WANG	2012-06-11	JUNCAI BAI	2012-06-11
001	2010-01-01	SNOW WANG	2011-07-01	JUNCAI BAI	2011-07-01

Plan Statistics for AMBIOPHARM, INC PROFIT SHARING PLAN

401k plan membership statisitcs for AMBIOPHARM, INC PROFIT SHARING PLAN

Measure Date Value
2022: AMBIOPHARM, INC PROFIT SHARING PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 275
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 198
Number of retired or separated participants receiving benefits 2022-01-01 1
Number of other retired or separated participants entitled to future benefits 2022-01-01 80
Total of all active and inactive participants 2022-01-01 279
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 0
Total participants 2022-01-01 279
Number of participants with account balances 2022-01-01 237
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 0
2021: AMBIOPHARM, INC PROFIT SHARING PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 245
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 186
Number of retired or separated participants receiving benefits 2021-01-01 16
Number of other retired or separated participants entitled to future benefits 2021-01-01 73
Total of all active and inactive participants 2021-01-01 275
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 275
Number of participants with account balances 2021-01-01 241
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 0
2020: AMBIOPHARM, INC PROFIT SHARING PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 211
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 193
Number of retired or separated participants receiving benefits 2020-01-01 2
Number of other retired or separated participants entitled to future benefits 2020-01-01 50
Total of all active and inactive participants 2020-01-01 245
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 245
Number of participants with account balances 2020-01-01 174
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 0
2019: AMBIOPHARM, INC PROFIT SHARING PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 168
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 165
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 46
Total of all active and inactive participants 2019-01-01 211
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 211
Number of participants with account balances 2019-01-01 142
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 1
2018: AMBIOPHARM, INC PROFIT SHARING PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 121
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 139
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 26
Total of all active and inactive participants 2018-01-01 165
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 165
Number of participants with account balances 2018-01-01 109
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 0

Measure	Date	Value
2022: AMBIOPHARM, INC PROFIT SHARING PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	275
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	198
Number of retired or separated participants receiving benefits	2022-01-01	1
Number of other retired or separated participants entitled to future benefits	2022-01-01	80
Total of all active and inactive participants	2022-01-01	279
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	0
Total participants	2022-01-01	279
Number of participants with account balances	2022-01-01	237
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	0
2021: AMBIOPHARM, INC PROFIT SHARING PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	245
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	186
Number of retired or separated participants receiving benefits	2021-01-01	16
Number of other retired or separated participants entitled to future benefits	2021-01-01	73
Total of all active and inactive participants	2021-01-01	275
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	275
Number of participants with account balances	2021-01-01	241
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	0
2020: AMBIOPHARM, INC PROFIT SHARING PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	211
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	193
Number of retired or separated participants receiving benefits	2020-01-01	2
Number of other retired or separated participants entitled to future benefits	2020-01-01	50
Total of all active and inactive participants	2020-01-01	245
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	245
Number of participants with account balances	2020-01-01	174
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	0
2019: AMBIOPHARM, INC PROFIT SHARING PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	168
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	165
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	46
Total of all active and inactive participants	2019-01-01	211
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	211
Number of participants with account balances	2019-01-01	142
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	1
2018: AMBIOPHARM, INC PROFIT SHARING PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	121
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	139
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	26
Total of all active and inactive participants	2018-01-01	165
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	165
Number of participants with account balances	2018-01-01	109
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	0

Financial Data on AMBIOPHARM, INC PROFIT SHARING PLAN

Measure	Date	Value
2022 : AMBIOPHARM, INC PROFIT SHARING PLAN 2022 401k financial data
Total unrealized appreciation/depreciation of assets	2022-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total income from all sources (including contributions)	2022-12-31	$386,187
Total loss/gain on sale of assets	2022-12-31	$0
Total of all expenses incurred	2022-12-31	$1,143,044
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$1,061,560
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$1,638,723
Value of total assets at end of year	2022-12-31	$6,293,885
Value of total assets at beginning of year	2022-12-31	$7,050,742
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$81,484
Total interest from all sources	2022-12-31	$1,009
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$1,054,155
Participant contributions at end of year	2022-12-31	$59,548
Participant contributions at beginning of year	2022-12-31	$22,132
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$100,000
Other income not declared elsewhere	2022-12-31	$37
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$-756,857
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$6,293,885
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$7,050,742
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Investment advisory and management fees	2022-12-31	$81,484
Value of interest in pooled separate accounts at end of year	2022-12-31	$6,006,797
Value of interest in pooled separate accounts at beginning of year	2022-12-31	$6,796,904
Interest on participant loans	2022-12-31	$1,009
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2022-12-31	$227,540
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2022-12-31	$231,706
Net investment gain/loss from pooled separate accounts	2022-12-31	$-1,253,582
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	No
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Contributions received in cash from employer	2022-12-31	$484,568
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$1,061,560
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	ELLIOTT DAVIS
Accountancy firm EIN	2022-12-31	570381582
2021 : AMBIOPHARM, INC PROFIT SHARING PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets	2021-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total income from all sources (including contributions)	2021-12-31	$2,525,369
Total loss/gain on sale of assets	2021-12-31	$0
Total of all expenses incurred	2021-12-31	$650,853
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$572,465
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$1,604,465
Value of total assets at end of year	2021-12-31	$7,050,742
Value of total assets at beginning of year	2021-12-31	$5,176,226
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$78,388
Total interest from all sources	2021-12-31	$1,615
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$909,148
Participant contributions at end of year	2021-12-31	$22,132
Participant contributions at beginning of year	2021-12-31	$35,038
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$258,213
Other income not declared elsewhere	2021-12-31	$153
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$1,874,516
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$7,050,742
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$5,176,226
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Investment advisory and management fees	2021-12-31	$78,388
Value of interest in pooled separate accounts at end of year	2021-12-31	$6,796,904
Value of interest in pooled separate accounts at beginning of year	2021-12-31	$4,950,297
Interest on participant loans	2021-12-31	$1,615
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2021-12-31	$231,706
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2021-12-31	$190,891
Net investment gain/loss from pooled separate accounts	2021-12-31	$919,136
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$437,104
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$572,465
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	ELLIOTT DAVIS
Accountancy firm EIN	2021-12-31	570381582
2020 : AMBIOPHARM, INC PROFIT SHARING PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets	2020-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total income from all sources (including contributions)	2020-12-31	$1,820,715
Total loss/gain on sale of assets	2020-12-31	$0
Total of all expenses incurred	2020-12-31	$551,703
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$499,162
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$1,077,587
Value of total assets at end of year	2020-12-31	$5,176,226
Value of total assets at beginning of year	2020-12-31	$3,907,214
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$52,541
Total interest from all sources	2020-12-31	$2,413
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$695,116
Participant contributions at end of year	2020-12-31	$35,038
Participant contributions at beginning of year	2020-12-31	$51,685
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$15,915
Other income not declared elsewhere	2020-12-31	$4
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$1,269,012
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$5,176,226
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$3,907,214
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Value of interest in pooled separate accounts at end of year	2020-12-31	$4,950,297
Value of interest in pooled separate accounts at beginning of year	2020-12-31	$3,697,478
Interest on participant loans	2020-12-31	$2,413
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2020-12-31	$190,891
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2020-12-31	$158,051
Net investment gain/loss from pooled separate accounts	2020-12-31	$740,711
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$366,556
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$499,162
Contract administrator fees	2020-12-31	$52,541
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Opinion of an independent qualified public accountant for this plan	2020-12-31	Disclaimer
Accountancy firm name	2020-12-31	SEROTTA MADDOCKS EVANS & CO., CPAS
Accountancy firm EIN	2020-12-31	581107697
2019 : AMBIOPHARM, INC PROFIT SHARING PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total transfer of assets to this plan	2019-12-31	$249
Total transfer of assets to this plan	2019-12-31	$249
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$1,572,169
Total income from all sources (including contributions)	2019-12-31	$1,572,169
Total loss/gain on sale of assets	2019-12-31	$0
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$193,395
Total of all expenses incurred	2019-12-31	$193,395
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$183,774
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$183,774
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$944,675
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$944,675
Value of total assets at end of year	2019-12-31	$3,907,214
Value of total assets at end of year	2019-12-31	$3,907,214
Value of total assets at beginning of year	2019-12-31	$2,528,191
Value of total assets at beginning of year	2019-12-31	$2,528,191
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$9,621
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$9,621
Total interest from all sources	2019-12-31	$2,876
Total interest from all sources	2019-12-31	$2,876
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Was this plan covered by a fidelity bond	2019-12-31	Yes
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$1,000,000
Value of fidelity bond cover	2019-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
If this is an individual account plan, was there a blackout period	2019-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$636,569
Contributions received from participants	2019-12-31	$636,569
Participant contributions at end of year	2019-12-31	$51,685
Participant contributions at end of year	2019-12-31	$51,685
Participant contributions at beginning of year	2019-12-31	$51,421
Participant contributions at beginning of year	2019-12-31	$51,421
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$10,768
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$10,768
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$1,378,774
Value of net income/loss	2019-12-31	$1,378,774
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$3,907,214
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$3,907,214
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$2,528,191
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$2,528,191
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Value of interest in pooled separate accounts at end of year	2019-12-31	$3,697,478
Value of interest in pooled separate accounts at end of year	2019-12-31	$3,697,478
Value of interest in pooled separate accounts at beginning of year	2019-12-31	$2,405,648
Value of interest in pooled separate accounts at beginning of year	2019-12-31	$2,405,648
Interest on participant loans	2019-12-31	$2,876
Interest on participant loans	2019-12-31	$2,876
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2019-12-31	$158,051
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2019-12-31	$158,051
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2019-12-31	$71,122
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2019-12-31	$71,122
Net investment gain/loss from pooled separate accounts	2019-12-31	$623,662
Net investment gain/loss from pooled separate accounts	2019-12-31	$623,662
Net gain/loss from 103.12 investment entities	2019-12-31	$956
Net gain/loss from 103.12 investment entities	2019-12-31	$956
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$297,338
Contributions received in cash from employer	2019-12-31	$297,338
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$183,774
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$183,774
Contract administrator fees	2019-12-31	$9,621
Contract administrator fees	2019-12-31	$9,621
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	SEROTTA MADDOCKS EVANS & CO., CPAS
Accountancy firm name	2019-12-31	SEROTTA MADDOCKS EVANS & CO., CPAS
Accountancy firm EIN	2019-12-31	581107697
Accountancy firm EIN	2019-12-31	581107697
2018 : AMBIOPHARM, INC PROFIT SHARING PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$599,803
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$455,588
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$454,675
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$750,091
Value of total assets at end of year	2018-12-31	$2,528,191
Value of total assets at beginning of year	2018-12-31	$2,383,976
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$913
Total interest from all sources	2018-12-31	$2,162
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$493,834
Participant contributions at end of year	2018-12-31	$51,421
Participant contributions at beginning of year	2018-12-31	$603
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$1,657
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$144,215
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$2,528,191
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$2,383,976
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Value of interest in pooled separate accounts at end of year	2018-12-31	$2,405,648
Value of interest in pooled separate accounts at beginning of year	2018-12-31	$2,343,727
Interest on participant loans	2018-12-31	$2,162
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2018-12-31	$71,122
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2018-12-31	$39,646
Net investment gain/loss from pooled separate accounts	2018-12-31	$-152,859
Net gain/loss from 103.12 investment entities	2018-12-31	$409
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$254,600
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$454,675
Contract administrator fees	2018-12-31	$913
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	SEROTTA MADDOCKS EVANS & CO., CPAS
Accountancy firm EIN	2018-12-31	581107697

Form 5500 Responses for AMBIOPHARM, INC PROFIT SHARING PLAN

2022: AMBIOPHARM, INC PROFIT SHARING PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	Submission has been amended	No
2022-01-01	This submission is the final filing	No
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Insurance	Yes
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement – Insurance	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: AMBIOPHARM, INC PROFIT SHARING PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Insurance	Yes
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement – Insurance	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: AMBIOPHARM, INC PROFIT SHARING PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	No
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Insurance	Yes
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement – Insurance	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: AMBIOPHARM, INC PROFIT SHARING PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Insurance	Yes
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement – Insurance	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: AMBIOPHARM, INC PROFIT SHARING PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Insurance	Yes
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement – Insurance	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes

Insurance Providers Used on plan

TRANSAMERICA FINANCIAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 70688 )

Policy contract number

601848-000

Policy instance

Insurance contract or identification number	601848-000
Insurance policy start date	2022-01-01
Insurance policy end date	2022-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $3,085
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Amount paid for insurance broker fees	3085
Additional information about fees paid to insurance broker	FEES
Insurance broker organization code?	5

TRANSAMERICA FINANCIAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 70688 )

Policy contract number

601848-000

Policy instance

Insurance contract or identification number	601848-000
Insurance policy start date	2021-01-01
Insurance policy end date	2021-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $3,092
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Amount paid for insurance broker fees	2229
Additional information about fees paid to insurance broker	FEES
Insurance broker organization code?	5

TRANSAMERICA FINANCIAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 70688 )

Policy contract number

601848-000

Policy instance

Insurance contract or identification number	601848-000
Insurance policy start date	2020-01-01
Insurance policy end date	2020-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $2,080
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Commission paid to Insurance Broker	USD $0
Amount paid for insurance broker fees	1303
Additional information about fees paid to insurance broker	FEES
Insurance broker organization code?	5

TRANSAMERICA FINANCIAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 70688 )

Policy contract number

601848-000

Policy instance

Insurance contract or identification number	601848-000
Insurance policy start date	2019-01-01
Insurance policy end date	2019-12-31
Total amount of commissions paid to insurance broker	USD $7,767
Total amount of fees paid to insurance company	USD $1,618
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Commission paid to Insurance Broker	USD $7,767
Insurance broker organization code?	3
Amount paid for insurance broker fees	873
Additional information about fees paid to insurance broker	FEES

TRANSAMERICA FINANCIAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 70688 )

Policy contract number

601848-000

Policy instance

Insurance contract or identification number	601848-000
Number of Individuals Covered	139
Insurance policy start date	2018-01-01
Insurance policy end date	2018-12-31
Total amount of commissions paid to insurance broker	USD $7,603
Total amount of fees paid to insurance company	USD $1,270
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Commission paid to Insurance Broker	USD $7,603
Amount paid for insurance broker fees	0
Additional information about fees paid to insurance broker	COMMISSIONS
Insurance broker organization code?	3

Potentially related plans

AMBIOPHARM, INC PROFIT SHARING PLAN [EIN = 900523510]

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	AMBIOPHARM, INC.
Employer identification number (EIN):	223940281
NAIC Classification:	541700

Jurisdiction of Incorporation:	Nevada Department of State
Incorporation Date:	2007-05-07
Company Identification Number:	20071702782
Legal Registered Office Address:	3520 WYNN RD SUITE 1 LAS VEGAS United States of America (USA) 89103